Sanofi (SNY)
44.40
-0.42
(-0.93%)
USD |
NASDAQ |
Aug 31, 16:00
44.40
0.00 (0.00%)
After-Hours: 20:00
Sanofi Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| December 31, 2014 | 17.93B |
| June 30, 2014 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2013 | 19.48B |
| June 30, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| December 31, 2009 | 11.45B |
| June 30, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| June 30, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| June 30, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| June 30, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| June 30, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| AstraZeneca PLC | 30.91B |
| GSK Plc | 18.51B |
| Johnson & Johnson | 37.34B |
| Eli Lilly & Co. | 49.62B |
| Merck & Co., Inc. | 51.08B |